Longboard Pharmaceuticals Valuation
| LBPH Stock | USD 59.98 0.00 0.00% |
At this time, the firm appears to be overvalued. Longboard Pharmaceuticals secures a last-minute Real Value of $30.5 per share. The latest price of the firm is $59.98. Our model forecasts the value of Longboard Pharmaceuticals from analyzing the firm fundamentals such as Current Valuation of 2.06 B, shares owned by insiders of 1.19 %, and Return On Equity of -0.47 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Longboard Pharmaceuticals' valuation include:
Price Book 8.5105 | Enterprise Value 2.1 B | Enterprise Value Ebitda (12.30) |
Overvalued
Today
Please note that Longboard Pharmaceuticals' price fluctuation is somewhat reliable at this time. Calculation of the real value of Longboard Pharmaceuticals is based on 3 months time horizon. Increasing Longboard Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Longboard Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Longboard Stock. However, Longboard Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 59.98 | Real 30.5 | Target 17.43 | Hype 59.9 | Naive 65.52 |
The intrinsic value of Longboard Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Longboard Pharmaceuticals' stock price.
Estimating the potential upside or downside of Longboard Pharmaceuticals helps investors to forecast how Longboard stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Longboard Pharmaceuticals more accurately as focusing exclusively on Longboard Pharmaceuticals' fundamentals will not take into account other important factors: When choosing an evaluation method for Longboard Pharmaceuticals, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using all methods to arrive at a better estimate.
Longboard Pharmaceuticals Cash |
|
Longboard Valuation Trend
Longboard Pharmaceuticals' real value analysis enables investors to forecast the earnings more efficiently. Using both Longboard Pharmaceuticals' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing decisions.
Longboard Pharmaceuticals Total Value Analysis
Longboard Pharmaceuticals is now projected to have valuation of 2.06 B with market capitalization of 2.34 B, debt of 475 K, and cash on hands of 87.42 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Longboard Pharmaceuticals fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
2.06 B | 2.34 B | 475 K | 87.42 M |
Longboard Pharmaceuticals Asset Utilization
One of the ways to look at asset utilization of Longboard is to check how much profit was generated for every dollar of assets it reports. Longboard Pharmaceuticals secures a negative usage of assets of -0.31 %, losing $0.003072 for each dollar of assets held by the firm. Inadequate asset utilization conveys that the company is being less effective with each dollar of assets it secures. Strictly speaking, asset utilization of Longboard Pharmaceuticals shows how discouraging it operates for each dollar spent on its assets.Longboard Pharmaceuticals Ownership Allocation
The majority of Longboard Pharmaceuticals outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Longboard Pharmaceuticals to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Longboard Pharmaceuticals. Please pay attention to any change in the institutional holdings of Longboard Pharmaceuticals as this could imply that something significant has changed or is about to change at the company.Longboard Pharmaceuticals Profitability Analysis
Net Loss for the year was (54.42 M) with profit before overhead, payroll, taxes, and interest of 0.About Longboard Pharmaceuticals Valuation
An absolute valuation paradigm, as applied to Longboard Stock, attempts to find the value of Longboard Pharmaceuticals based on its fundamental and basic technical indicators. By analyzing Longboard Pharmaceuticals's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Longboard Pharmaceuticals's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Longboard Pharmaceuticals. We calculate exposure to Longboard Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Longboard Pharmaceuticals's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -4.5 K | -4.7 K |
Longboard Pharmaceuticals Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 22.7 M |
Longboard Pharmaceuticals Current Valuation Indicators
Valuation refers to the process of determining the present value of Longboard Pharmaceuticals and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Longboard we look at many different elements of the entity such as Longboard's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Longboard Pharmaceuticals, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Longboard Pharmaceuticals' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Longboard Pharmaceuticals' worth.Complementary Tools for Longboard Stock analysis
When running Longboard Pharmaceuticals' price analysis, check to measure Longboard Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Longboard Pharmaceuticals is operating at the current time. Most of Longboard Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Longboard Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Longboard Pharmaceuticals' price. Additionally, you may evaluate how the addition of Longboard Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |